Trial Profile
Phase I study of anhydrovinblastine in patients with advanced refractory solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Anhydrovinblastine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 04 Oct 2005 New trial record.